Major barriers include the immunosuppressive tumor microenvironment (TME); heterogeneous or low antigen expression; antigen loss; poor tumor infiltration; and T cell exhaustion driven by the persistent stimulation of inhibitory receptors, such as PD-1 and LAG-3 [3]. Here, LAG3 is linked to neoplasm.